|
Singh, Rana P; Agarwal, Rajesh (2009) Cosmeceuticals and silibinin. Clin Dermatol 27:479-84
|
|
Ramasamy, Kumaraguruparan; Agarwal, Rajesh (2008) Multitargeted therapy of cancer by silymarin. Cancer Lett 269:352-62
|
|
Deep, Gagan; Agarwal, Rajesh (2008) New combination therapies with cell-cycle agents. Curr Opin Investig Drugs 9:591-604
|
|
Raina, Komal; Agarwal, Rajesh (2007) Combinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms. Acta Pharmacol Sin 28:1466-75
|
|
Kaur, Manjinder; Agarwal, Rajesh (2007) Silymarin and epithelial cancer chemoprevention: how close we are to bedside? Toxicol Appl Pharmacol 224:350-9
|
|
Gu, Mallikarjuna; Singh, Rana P; Dhanalakshmi, Sivanandhan et al. (2007) Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res 67:3483-91
|
|
Singh, Rana Pratap; Agarwal, Rajesh (2006) Natural flavonoids targeting deregulated cell cycle progression in cancer cells. Curr Drug Targets 7:345-54
|
|
Mohan, Sarumathi; Dhanalakshmi, Sivanandhan; Mallikarjuna, G U et al. (2004) Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. Biochem Biophys Res Commun 320:183-9
|
|
Singh, Rana P; Agarwal, Rajesh (2004) Prostate cancer prevention by silibinin. Curr Cancer Drug Targets 4:1-11
|
|
Singh, Rana P; Agarwal, Rajesh (2003) Tumor angiogenesis: a potential target in cancer control by phytochemicals. Curr Cancer Drug Targets 3:205-17
|
